IMV Inc IMVIF

Our Ovarion Cancer data continues to be better than the rest

[cribbons]

[cribbons]

[gardy]

And your point is? The old management team was talking about this 10 years ago in Vancouver when I met with them. Again where are we now, 10 years later? Gardy

[Breakthorough]

We are, if DLBCL data are replicated in Phase 2b, just about one year from accelerated approval in one indication. Which will give time to let ovarian data be mature enough in the meanwhile (the best point in them doesn't seem to be ORR, but duration, and it takes time). Unfortunately, we don't have data abour the Basket Trial ebenthough one can speculate about liver and MSI-H cancers data

[Breakthorough]

I said liver and MSI-H and should have said bladder, MSI-H and, may be, liver.